Based onAmerican Heart Association, the cardiovascular disease is the leading global cause of death, accounting for over 17.3 million deaths per year. Prior to recent medical innovations, traditional treatment was considered invasive and quite risky, but new and improved operational options have opened up thanks in part to 3D printing technology.Nowadays after specialized in developing, manufacturing and selling of 3D printed silicone vascular models and medical simulators for over 20 years, TrandoMed, A China’s first professional manufacturer in the medical 3D printing field, has continuously updated its 3D technology research and development and conducted medical device innovation.
TrandoMed integrated 3D printing technology into their business model, which has helped surgeons both learn and teach advanced endovascular techniques through 3D printed models that assimilate certain disease and patient-specific scenarios. By utilizing 3D printing solutions, these silicone-based vessel models can be designed and manufactured to replicate almost any blood vessel, directly and accurately prototyped from the actual patient in question. The ability to replicate the anatomy of a diseased patient is what makes this process superior to other traditional training models.